Diethylamine

Diethylamine

SCHEMBL9701283

CCCN(C)C(=O)C(=O)O.CCNCC

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.33
TP53 P04637 1/20 0.33
KDM5A P29375 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL9700399 0.87 EPHX2 (0.35) EPHX2KDM5AKDM4CCA12CA2
Diethylamine SCHEMBL9701558 0.83 TP53 (0.36) TP53
SCHEMBL42469 0.74
SCHEMBL23617956 0.72 EPHX2 (0.33) EPHX2KDM5AKDM4CCA12CA2
Hydrochloric Acid SCHEMBL10822824 0.72
Oxalic Acid SCHEMBL5875441 0.71 TP53 (0.57) TP53
Oxalic Acid SCHEMBL5875439 0.71 TP53 (0.57) TP53
SCHEMBL9702710 0.70 CA12 (0.36) EPHX2KDM5AKDM4CCA12CA2
SCHEMBL14098937 0.70 EPHX2 (0.38) EPHX2TP53CA12CA2CA9
SCHEMBL9701553 0.70 MCHR1 (0.35) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5132454-A Antihypoxic agents MEIJI SEIKA KAISHA, LTD. (JP) 1992-07-21 US disclosed
US-5066677-A Antihypoxic agents, treatment of disorders resulting from reduced oxygen supply to brain MEIJI SEIKA KAISHA, LTD. (JP) 1991-11-19 US disclosed
EP-0387074-A2 Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain MEIJI SEIKA KAISHA LTD. (JP) 1990-09-12 EP disclosed